Barbara Simon, MD: Advances in Insulin for Diabetic Patients

March 31, 2022
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

There are now more insulin options for patients with diabetes than ever before.

There are more options of insulin for diabetic patients than ever.

With many different formulations of insulin available, many advocates have honed in on cost as a key barrier preventing better care for patients with diabetes.

Recently, during HCPLive’s® State of the Science event called New Advances in Insulin Therapy for the Management of Type 2 Diabetes a panel of experts spoke about new and emerging treatment for diabetes and what challenges still remain in care.

In an interview with HCPLive, Barbara Simon, MD, associate professor of endocrinology, Sidney Kimmel Medical Center at Thomas Jefferson University discussed the panel and gave an overview on the current state of diabetes care.